RehabCare Group, Inc. - Strategic SWOT Analysis Review

RehabCare Group, Inc. (RehabCare) provides physical rehabilitation program management services. It is a subsidiary of Kindred Healthcare, Inc. RehabCare also offers post-acute program management, physical therapy rehabilitation, medical direction, quality assurance, specialty programs, compliance review, and census development services through partnerships with healthcare providers.  The company offers its services to hospitals, skilled nursing facilities, outpatient facilities, and other long-term care facilities. It provides other healthcare services such as healthcare management consulting services and staffing services for therapists and nurses.

To Know more about :  RehabCare Group, Inc.

Best World International Ltd (Best World) is a Health and Wellness products Retailer Company

The company develops and sells nutritional supplements, personal care, health care, skincare and wellness products. It retails products of various brands including Avance, Optrimax, Foodphilo, DR's Secret, Miraglo, PentaLab, UberAir, Pureflo and others. Best World provides its products through direct selling, agencies and other retailers. It operates through a network of more than 250,000 independent distributors and customers in Singapore, Malaysia, Indonesia, Hong Kong, Taiwan, Thailand, Australia, Brunei and Vietnam. The company was incorporated in the year 1990. Best World is headquartered in Singapore.

Know more about : Best World International Ltd

Strength and Weaknesses of Maxim Pharmaceuticals, Inc.

This comprehensive SWOT profile of Maxim Pharmaceuticals, Inc. provides you with an in-depth strategic analysis of the company's businesses and operations. The profile will give you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

Business description – A detailed description of the company's operations and business divisions.
- Corporate strategy – Analyst's summarization of the company's business strategy.
- SWOT Analysis – A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company. 

Know more about : Maxim Pharmaceuticals, Inc.

Comprehensive SWOT profile of Orient Pharma Co., Ltd.

This comprehensive SWOT profile of Orient Pharma Co., Ltd. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Orient Pharma Co., Ltd. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Know more about :  Orient Pharma Co., Ltd.

Comprehensive SWOT profile of Hanmi Pharm Co., Ltd.

The profile will give you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the 'Profile on Demand' Service, covering over 50,000 of the world's leading companies. Once purchased, We will comprehensively research and author a full strategic analysis of Hanmi Pharm Co., Ltd. and deliver this direct to you in pdf format within two business days (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company's operations and business divisions.
- Corporate strategy – Analyst's summarization of the company's business strategy.
- SWOT Analysis – A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives' employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

For more information about : Hanmi Pharm Co., Ltd.

Get Detailed Information About the Applied NeuroSolutions, Inc. Company

Applied NeuroSolutions, Inc. (APNS) is a development stage biopharmaceutical company engaged in the research and development of products for the diagnosis and treatment of Alzheimer’s disease (AD). Its core technology is based on exclusive licensing agreement with Albert Einstein College of Medicine (AECOM), which covers all diagnostic and therapeutic applications in the field of neurodegenerative disease. The company strongly focuses on its research and development activities to develop new products and launch in the market sooner. Currently, APNS is working on both cerebrospinal fluid (CSF) based tests and serum based tests to detect AD at an early stage. The company is headquartered in Illinois, the US.

This comprehensive SWOT profile of Applied NeuroSolutions, Inc. provides you with an in-depth strategic analysis of the company's businesses and operations. The profile will give you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.


For more information kindly visit :  Applied NeuroSolutions, Inc.

New Frontiers in Cell Line Development and Opportunities for Biosimilars

Conference Description

Key Speakers Include:-

Arun Bhatt, President, Clininvent Research 

R. H. Jani, Senior Vice President, Clinical R&D, Cadila

Purnima Sharma, Managing Director, Biotech Consortium India Limited BCIL

Annaswamy Vaidheesh, Vice President- Government affairs Asia Pacific, Johnson & Johnson

Bobby George, Asssitant Vice President and Head, Regulatory Affairs, Reliance Life Sciences

Dilip Pawar, Director and Head Clinical Development, Dr Reddys

Kaustubh Berde, Vice President & Head - International Formulations, Panacea Biotec

Yatin Gokarn, Narotam Sekhsaria Distinguished Professor of Chemical Engineering, Institute of Chemical Technology.

(Former Associate Director, Genentech (San Francisco)

Anurita Majumdar, Director - Medical & Regulatory - India & South Africa, Eli Lilly

Chirag Trivedi, Associate Director - Project Management & Strategic Initiatives, Sanofi-Aventis

Kedar Suvarnapathaki, Head - Regulatory Affair, Boehringer Ingelheim

Yasmin Shenoy, Director-Regulatory Affairs, Sanofi-Aventis

Milind Antani, Head-Pharma LifeSciences group, Nishith Desai Associates

Plus Many More...

The recent establishment of regulatory guidelines for biosimilars in India is expected to add further momentum to the growth of the global biosimilars market. Increasing pressure from governments and insurers for greater biologic competition, there exists an incredible opportunity for biosimilar producers to capitalise on what is set to become the fastest growing sector of the pharmaceutical industry. Due to the limited clinical database at the time of approval of a biosimilar, vigorous pharmacovigilance is required. & Biosimilars are set to become an important part of the future medicines market.

To know more about conferences on : 

3rd Biosimilars Congregation 2013

Breathe Technologies, Inc. - Medical Equipment Company

Breathe Technologies, Inc. (Breathe Technologies) is a health-care solutions provider, based in the US. The company develops and manufactures the therapeutic respiratory systems. The respiratory systems are useful to patients of various respiratory illnesses such as emphysema, chronic bronchitis, cystic fibrosis, influenza, among other respiratory conditions that limit normal breathing. Its products include ultra lightweight, compact, wearable mobile ventilator system that helps during breathing problems and is useful for heart – patients. The company develops solutions for empowering healthcare providers and patients with reliable and accessible respiratory therapies that optimize breathing and mobility. Breathe Technologies is headquartered in San Ramon, California, the US.

Breathe Technologies, Inc. - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. 

To know more about : Breathe Technologies, Inc

Smith & Nephew, Inc. - Medical Equipment - Deals and Alliances Profile

Smith & Nephew, Inc. is a medical device company. It carries out the development, manufacture and marketing of medical devices. The company manufactures orthopedic reconstruction and trauma, endoscopy, and advanced wound management equipment. It offers its products for surgeons and hospitals. The company is a subsidiary of Smith & Nephew Plc. Smith & Nephew, Inc is headquartered in Memphis, Tennessee, the US.

Smith & Nephew, Inc. - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

To know more :  Smith & Nephew, Inc

Digital Healthcare Ltd - Medical Equipment - Deals and Alliances Profile

Digital Healthcare Ltd, (DHC) is an UK-based company that provides software solutions for eye screening and technology to manage information and images in clinical ophthalmology. The products offered by the company include, OptoMize Retinopathy Screening, the USed to detect early and previously undiagnosed signs of diabetic retinopathy and other causes of blindness, Retasure, the USed by diabetic patients for assessment of their retinal health and OcuLab, the USed in Ophthalmology Departments, to integrate clinical instruments and distribute information across their institutions. The solutions of DHC are namely, OptoMize, Diabetic Retinopathy Screening, OptoMize, Systematic Population Screening , NHS HealthChecks, OcuLab, Enterprise Ophthalmology and Retasure, Retinal Risk Assessment. DHC is headquartered in Cambridge, the UK.

Digital Healthcare Ltd - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical Equipment eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including M&A, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as M&A, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

For more information visit : Digital Healthcare Ltd - Medical Equipment - Deals and Alliances Profile

Baylis Medical Company Inc. is a pharmaceuticals and healthcare company

Baylis Medical Company Inc. (Baylis Medical) is a pharmaceuticals and healthcare company, based in Canada. The company operates through its segments cardiology, vascular, pain management and interventional neurology. It develops, manufactures and markets medical products for the healthcare markets. Its products include Pain Management Products include Single use Probe Kits, transdiscal system, neurological Probes and datastream Data Recording Software. Cardiology Products include Baylis RF Pain Management System, Radio frequency Puncture Generator and BMC Pro Track Micro catheter. Radiology Products include RF Puncture System Accessories, Return Electrode and Footswitch. Baylis Medical products are utilized by cardiologists, interventional radiologists and electrophysiologists. The company distributes and markets its products through its brands RadiOpaque, DataStream, TransDiscal System, Baylis Integra, Torflex, PowerWire and ProTrack. It is ISO 13485:2003 certified company. Baylis Medical is headquartered in Quebec, Canada.

Baylis Medical Company Inc. - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical Equipment eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including M&A, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as M&A, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

More information on Baylis Medical Company Inc.

Kane Biotech Inc. (Kane Biotech) is a biotechnology company

Kane Biotech Inc. (Kane Biotech) is a biotechnology company that develops and commercializes products to prevent and disperse microbial biofilms. The company utilizes patented technologies, namely, Aledex and DispersinB and competence stimulating peptide (CSP) signaling system, for the development the product candidates.  The Aledex pipeline products include the urinary catheter coating, venous catheter coating and veterinary catheter coating. DispersinB's product pipeline consists of wound gels, wound dressings, venous catheter coating and cystic fibrosis. CSP technology's product pipeline includes a novel mouthwash and toothpaste additive. Kne Biotech has partnership with Harland Medical Inc and Ward Biotech for the development of the product candidates. Kane Biotech is headquartered in Winnipeg, Manitoba, Canada.

Kane Biotech Inc. (KNE) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical Equipment eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including M&A, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as M&A, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

More information on Kane Biotech Inc. (KNE) - Medical Equipment - Deals and Alliances Profile

Frost Group, LLC - Medical Equipment - Deals and Alliances Profile

Frost Group, LLC is a private investment firm. These investments include stakes in the areas of pharmaceuticals, diagnostic devices, medical devices, developmental education and entertainment for children, telecommunications, sports licensing, aviation services, software for seismic data analysis, and new materials for computer chips.

Frost Group, LLC - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical Equipment eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including M&A, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as M&A, Equity/Debt Offering etc.

For more information visit :  Frost Group, LLC - Medical Equipment

Swot Analysis Review of Kilitch Drugs (India) Ltd. (KILITCH) Compnay

Kilitch Drugs (India) Ltd. (Kilitch) is a publicly held pharmaceutical company engaged in manufacturing and marketing of various range of formulations in solid, liquid and parent forms. The company offers contract manufacturing service to national and multinational pharmaceutical companies. Kilitch has tie-ups with more than 20 leading pharmaceutical companies, including Ranbaxy Laboratories Limited, Sand India Limited, Merck Limited, Zydus Cadillac, Nicholas Primal India Limited, USV Limited and others for exports. It's product portfolio include carabineer, cephalosporin, beta, lactate antibiotics, steroids and hormones, gastro logy related drugs, NSAIDs, anti malarial, aminoglycosides and other anti-infectives. Flitch exports its products to Algeria, Burundi, Cameroon, Tanzania, Uganda, Eritrea, Russia, Senegal, Ghana, Iraq, Nigeria Lanka, Tchad, Niger, Ethiopia, Yemen, Sudan. It is specialized as a manufacturer of antibacterial parent formulations and as producers of sterile liquid formulations in small volumes. Kilitch is headquartered at Mumbling in Maharashtra, India.

This comprehensive SWOT profile of Kilitch Drugs (India) Ltd. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.

For more information visit :  Kilitch Drugs (India) Ltd. (KILITCH)

MetaStat, Inc. (MTST) - Product Pipeline Analysis

MetaStat, Inc., (MetaStat) formerly known as Photovoltaic Solar Cells Inc., is a life science company. It focuses on the development of proprietary clinical diagnostic tests. The company's product portfolio consists of MetaSite Breast, developed to predict the spread of cancer through the bloodstream to other organs; MenaCalc Lung, a test evaluated to predict the likelihood of metastasis in adenocarcinoma of the lung; MenaCalc Prostate, a diagnostic for prostate cancer; and MenaBloc, a platform technology that provides a target to develop therapies that can preemptively reduce or eliminate metastasis. It develops these products using mena protein, a potentiator and modulator of cellular migration. The company operates a wholly-owned subsidiary, namely, MetaStat BioMedical, Inc. MetaStat is headquartered in The Woodlands, Texas, the US.

This report is a source for data, analysis and actionable intelligence on the MetaStat, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

For more information on MetaStat, Inc. (MTST) - Product Pipeline Analysis.

MicroTransponder Inc. - Product Pipeline Analysis

MicroTransponder Inc. (MicroTransponder) is a medical device company. It is a spun out from the University of Texas. The company carries out the development of neurostimulation solutions to treat neurological diseases. The company offers systems for the treatment of various neurological diseases, including tinnitus, autism and post stroke motor rehabilitation. The company’s serenity system, which pairs an Vagus Nerve Stimulation, is used to treat over 60,000 patients for epilepsy and depression. MicroTransponder is headquartered in Dallas, Texas, the US.

The company’s continous focus on the neuroscience related to the condition of tinnitus helped it to develop a novel therapy. Recently, the company presented data from the initial 10-patient tinnitus clinical trial at the Tinnitus Research Initiative conference in Belgium.

This report is a source for data, analysis and actionable intelligence on the MicroTransponder Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.

For more information on MicroTransponder Inc. - Product Pipeline Analysis

Aesculap: Strategic Analysis of Leading Orthopedics Companies

A strategic assessment of Aesculap, one of the world' s leading orthopedics companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company 's performance, capabilities, goals and strategies in the global orthopedics market.

Executive Summary Business Organization Senior Management Facilities and Employees Technological Know-how Product Portfolio Marketing Tactics Sales and Profit Growth R&D Expenditures and Major Programs Collaborative Arrangements Strategic Direction List of Tables Aesculap Sales and Operating Profit Growth Aesculap Sales by Division Aesculap Sales Growth by Division Aesculap Sales by Geographic Region Aesculap Sales Growth by Geographic Region

For more information kindly visit : Aesculap: Strategic Analysis of Leading Orthopedics Companies

DiaPat GmbH - Product Pipeline Analysis

Diapat Gmbh (Diapat) is a diagnosis services provider. The company provides diagnosis of various diseases such as coronary artery disease, diabetic nephropathy, bladder cancer, chronic nephropathies, heart failure and vesicoureteral reflux. It specilaizes in the reliable detection of diseases at early stages and evaluation of therapy, enabling personalized medicine. The company's DiaPat technology based on the innovative coupling of capillary electrophoresis and mass spectrometry identifies up to 6,000 of the proteins and polypeptides. It conducts research and development activities in partnership with universities and institutes including Harvard University, Beatson Institute, NHFML University of Florida and Austin Health. Diapat is headquartered in Hannover, Germany.

This report is a source for data, analysis and actionable intelligence on the DiaPat GmbH portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.

For more information visit : DiaPat GmbH - Product Pipeline Analysis

Aragon Pharmaceuticals, Inc. - Product Pipeline Review - 2012

Aragon Pharmaceuticals, Inc. - Product Pipeline Review - 2012” provides data on the Aragon Pharmaceuticals, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Aragon Pharmaceuticals, Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from Aragon Pharmaceuticals, Inc. and industry-specific third party sources, put together by Global Markets Direct’s team. Scope - Aragon Pharmaceuticals, Inc. - Brief Aragon Pharmaceuticals, Inc. overview including business description, key information and facts, and its locations and subsidiaries. - Review of current pipeline of Aragon Pharmaceuticals, Inc. human therapeutic division. - Overview of pipeline therapeutics across various therapy areas. - Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe. and Swot Analysis - Product profiles for late stage and clinical stage products of Aragon Pharmaceuticals, Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones. - Recent updates of the Aragon Pharmaceuticals, Inc.’s pipeline in the last quarter. - Key discontinued and dormant projects. - Latest news and deals relating to the products. Reasons to buy - Evaluate Aragon Pharmaceuticals, Inc.’s strategic position with total access to detailed information on its product pipeline. - Assess the growth potential of Aragon Pharmaceuticals, Inc. in its therapy areas of focus. - Identify new drug targets and therapeutic classes in the Aragon Pharmaceuticals, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas. - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps. - Exploit collaboration and partnership opportunities with Aragon Pharmaceuticals, Inc.. - Avoid Intellectual Property Rights related issues. - Explore the dormant and discontinued projects of Aragon Pharmaceuticals, Inc. and identify potential opportunities in those areas. For more information on Aragon Pharmaceuticals, Inc.

Alafair Biosciences, Inc. - Product Pipeline Analysis

Alafair Biosciences, Inc.( Alafair) is a medical equipment company. It develops cross-linked polysaccharide hydrogel films to address the post-surgical complication of unwanted soft tissue attachments or tethering between opposing tissue surface. Alafair’s initial product is a film that shows superior handling and mechanical properties. Its follow-on product pipeline includes membrane, bilayer, and injectable gel solutions for applications in scar prevention, wound care, and tissue reconstruction. The company has a sponsored research agreement with the university of Texas and has acquired world-wide exclusive rights to the hydrogel platform technology from the university for all fields of use. The company is headquartered at Austin, Texas, the US.

This report is a source for data, analysis and actionable intelligence on the Alafair Biosciences, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by industry experts.

Scope

- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

For more information on Alafair Biosciences, Inc.